the INM (15) and can relocalize certain ER membrane proteins to the INM, such as Sec61 (15) . We generated GFP-h2NLS-L-(Sec61-2), a Sec61-2 derivative fused at the N terminus to a high-affinity NLS, a long unstructured domain (L), and GFP. In wt cells, GFP-h2NLS-L-(Sec61-2) displayed an extremely short half-life, whereas in hrd1Dasi1D mutants it was strongly stabilized (Fig. 4B ) and accumulated at the nuclear envelope ( fig. S10A ). Preventing GFP-h2NLS-L-(Sec61-2) from targeting the INM, either by removing the NLS or by shortening the linker (15) , increased the dependency of its degradation on Hrd1 while decreasing the requirement for Asi1 (Fig. 4, B and C, and fig.  S10A ). The degradation of all chimeric constructs was due to the Sec61-2 mutation, as equivalent chimeras to wt Sec61 were stable ( fig. S10B) . Thus, the quality control of misfolded ER membrane proteins is spatially segregated, with the Asi complex acting on substrates localized to the INM.
To assess how general this role of the Asi complex in quality control is, we took advantage of the genetic interaction between ERAD and the unfolded protein response (UPR), a rectifying transcriptional program triggered by an increased ER load of misfolded proteins (16, 17) . UPR mutants, such as ire1D, depend on ERAD to survive, particularly under stress conditions such as high temperature (16, 17) . Asi complex mutations in UPR-deficient cells did not affect cell fitness (Fig. 4D) , consistent with the observation that single Asi complex mutants efficiently degrade all tested ERAD substrates ( fig. S8 ). In contrast, cells lacking Ire1, Hrd1, and an Asi complex core component were not viable (Fig.  4D and fig. S11 ). In agreement with the less prominent role of Asi2 in the degradation of misfolded Sec61-2 (fig. S9B), hrd1Dire1Dasi2D mutants had a milder growth defect ( fig. S11 ). Thus, the Asi complex plays an important function in protein quality control and contributes to ER homeostasis.
Our results identify an ERAD branch defined by the Asi complex. Like the other branches, Asi mediates the degradation of both misfolded proteins and regulators of sterol biosynthesis. A distinctive feature of the Asi complex is its INM localization ( fig. S12 ). Doa10 localizes both to the INM and the rest of the ER, and can target substrates in the nucleoplasm as well as in the cytoplasm (13) . Because the ER encloses a continuous luminal space, the Hrd1 complex can target all misfolded luminal proteins. In contrast, INM misfolded proteins are not accessible to Hrd1, because it is excluded from this ER subdomain (13) . Sequence analysis reveals obvious Asi complex homologs only in fungi. If a functional homolog of the Asi complex exists in higher eukaryotes, it might become critical in postmitotic cells that do not undergo frequent nuclear envelope disassembly and reassembly events, known to "refresh" the pool of INM proteins (9) .
Asi1, Asi2, and Asi3 control AAP gene expression in response to amino acid availability, a process mediated by the transcription factors Stp1 and Stp2 (7, 8, 10) . Even if the turnover of Stp1 or Stp2 is not affected by Asi complex mutations, Asi1 ubiquitin ligase activity is essential to control the response to amino acids (7). Intriguingly, the Cdc48 ATPase complex inhibits transcription in a proteolysis-independent manner by preventing ubiquitinated transcription factors from binding to their target sequences (18) . Whether these functions of Cdc48 and Asi complexes in gene regulation are linked is unclear. However, an appealing possibility is that the ERAD machinery at the INM has been co-opted to perform additional functions, such as controlling transcription factor activity.
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To investigate whether MuNoVs infect B cells in culture, M12 and WEHI-231 mouse B cell lines were infected with either MNV-1 or MNV-3. These two MuNoV strains were selected because they display numerous pathogenic distinctions. Specifically, MNV-1 establishes an acute infection, whereas MNV-3 establishes persistence (16-18) ; MNV-3 is attenuated compared with MNV-1 (19); and MNV-3 elicits more robust protective immunity than does MNV-1 (14) . Both MuNoV strains replicated efficiently in the B cell lines, although peak titers were reached~1 day later than in mouse RAW264.7 macrophages, a cell line known to be permissive to MuNoVs (Fig. 1A) (20) fig. S1 ). MuNoV infection of M12 cells did not result in visible cytopathic effect (CPE), a finding that was confirmed by using propidium iodide staining (Fig. 1B) . S1 ).
To determine percent infectivity, cells were stained for the MuNoV protease-RdRp (ProPol) nonstructural proteins. Although 80 to 90% of RAW264.7 and WEHI-231 cells were productively infected, only 5 to 15% of M12 cells were productively infected (Fig. 1C and fig. S2 ). To determine whether M12 cultures cleared this low-level infection or instead became persistently infected, we measured virus titers in supernatant fluid after repeated passaging of infected cultures. We consistently detected 10 6 to 10 7 median tissure culture infectious dose (TCID 50 )/mL of each virus in the supernatant through 25 culture passages, which correlated with consistent low infection frequency and positive staining for the viral VP1 protein (Fig. 1D) . Similarly, MNV-3 established persistent infection in WEHI-231 cells after the initial drop in cell viability. Thus, MuNoVs can persistently infect B cells in culture.
We used several complementary approaches to confirm that B cells are bona fide NoV targets in vivo. First, MNV-1 and MNV-3 titers were significantly reduced in the distal ileum and mesenteric SCIENCE sciencemag.org .The data are presented as the fold-increase in genomes from 0 to 3 dpi. In two experiments, unfiltered stool was applied to a coculture with no cells in the basal chamber as a control (white bars). The 3-dpi genome copy numbers were compared with 0 dpi under each condition for statistical purposes, indicated by black asterisks. Similar coculture results were obtained by using another GII.4-Sydney HuNoV-positive stool sample. For all, error bars denote mean T SD; Student's t test, *P < 0.05, **P < 0.01, ***P < 0.001.
lymph nodes (MLNs) of B cell-deficient mice (mMT mice) as compared with B6 mice (Fig. 2, A  and B) . To test whether the reduced virus titers in mMT mice reflected decreased viral replication or increased clearance of input virus, we infected mice with light-sensitive MNV-1 to allow differentiation between input and newly replicated virus [this assay, along with complete methods, are described in (21)]. No significant differences in the ratio of light-insensitive (newly replicated) to total virus titers were observed between B6 and mMT mice ( fig. S3A ), demonstrating that B cells are required for optimal viral replication in vivo. Further supporting in vivo B cell infection, B cells purified from Peyer's patches of wildtype B6 mice contained viral genomes (Fig. 2C) . Although MuNoV nonstructural protein expression has not been demonstrable in any cell type from in vivo samples of wild-type animals, we did observe viral nonstructural protein in B cells from Peyer's patches of Stat1 −/− mice, in which MuNoVs achieve higher titers (Fig. 2D) . Together, these findings suggest that B cells are infected in vivo during NoV infections. On the basis of our observations with MuNoVs, we asked whether HuNoVs infect B cells. The currently dominant HuNoV strain circulating worldwide is a genogroup II, genotype 4 (GII.4) strain called GII.4-Sydney (22, 23) . When a GII.4-Sydney HuNoV-positive stool sample was inoculated onto the BJAB human B cell line, there was a significant 10-fold and 25-fold increase in viral genome copy number at 3 and 5 dpi, respectively, compared with input levels (Fig. 3, A and B, and  fig. S4 ). Genome replication was not observed when the stool sample was ultraviolet (UV)-inactivated before inoculation. Filtration of the HuNoV-positive stool sample over a 0.2-mm membrane decreased genome replication, suggesting the presence of a filterable cofactor (Fig. 3, A and  B) . Viral nonstructural and structural proteins were detected in cells inoculated with unfiltered stool inoculum by using Western blotting and immunofluorescence assay, respectively (Fig. 3, C  and D) , although BJAB cultures were not persistently infected (figs. S5 and S6). To determine whether viral genome replication and protein synthesis in BJAB cells were indicative of productive infection, lysates from BJAB cultures at 3 dpi were passaged onto naïve BJAB cells ( fig. S5 ). HuNoV genomes increased fourfold and 20-fold at 3 and 5 dpi, respectively, after inoculation with passage 0 (P0) virus (Fig. 3E) , indicating that primary BJAB infection results in the production of new infectious virus particles.
Because NoVs must breach the intestinal epithelium in order to access target B cells, we also tested HuNoV infection in a coculture system with polarized HT-29 intestinal epithelial cells (IECs). GII.4-Sydney HuNoV-positive stool was applied into the apical supernatant fluid of HT-29 IECs grown on a transwell with BJAB B cells in the basal chamber. A nearly 600-fold increase in viral genome copy number was detected in the B cell fraction of infected cultures at 3 dpi when unfiltered inoculum was tested (Fig. 3F) . No increase was detected in the basal chamber in the absence of B cells. Moreover, filtration of the stool sample ablated B cell-associated viral genome replication, which is consistent with results in direct B cell infections.
On the basis of the reduced B cell infectivity we observed in filtered stool samples, we tested whether enteric bacteria could serve as a cofactor to facilitate HuNoV infection of B cells. HuNoVs are well known to bind histo-blood group antigens (HBGAs) (24, 25) , which are expressed by the host as well as by certain bacteria (26) (27) (28) . We first tested Enterobacter cloacae because it expresses H type HBGA (Fig. 4A) that the GII.4-Sydney HuNoV strain can bind (29) . Filtered stool containing GII.4-Sydney virus displayed a dose-dependent restoration of infectivity when incubated with E. cloacae before inoculation of BJAB B cells (Fig. 4B) . Neither Escherichia coli (which did not express H antigen) nor lipopolysaccharide (LPS, a component of the outer membrane of Gram-negative bacteria) rescued infectivity, whereas synthetic H antigen restored infectivity of filtered stool comparably with E. cloacae. Antibody to VP1 neutralized infectivity of the unfiltered stool, as expected. Providing insight into the mechanism of H antigen-mediated stimulation, filtration of GII.4-Sydney HuNoV-positive stool inoculum ablated virus attachment to B cells, and synthetic H antigen was sufficient to restore attachment (Fig. 4C) . Overall, these results demonstrate that HuNoV interactions with enteric bacteria, likely CFU heat-killed E. coli, 1 mg/mL E. coli LPS, or 500 ng/mL synthetic H-type HBGA before inoculation onto B cells. To test for antibody-mediated neutralization of virus infectivity, unfiltered stool inoculum was incubated with 10 mg/mL antibody to VP1 before B cell inoculation. Viral genome copy numbers were determined at 0 and 3 dpi under each condition (n = 3 to 4 experiments). Data are reported as the fold-increase in copy numbers over time. Each condition was compared with the untreated filtered inoculum data set for statistical purposes. (C) Unfiltered stool (black bars), filtered stool (gray bars), or filtered stool preincubated with 500 ng/mL H antigen (white bars) was inoculated onto BJAB cells for the indicated times at 4°C (n = 4 experiments). Viral genome copy numbers were quantified from unwashed cells to determine the amount of input virus and from washed cells to determine the amount of cell-attached virus. Data are reported as the percent of viral genomes remaining cell-associated compared with input. (D) Groups of phosphate-buffered saline (PBS)-treated (black bars) and Abxtreated (white bars) B6 mice (n = 3 to 4 mice) were infected with 10 7 TCID 50 units MNV-1 (left) or MNV-3 (right). At 1 dpi, virus was titered from the distal ileum (DI), colon, and mesenteric lymph nodes (MLNs) by using a standard virus plaque assay (n = 3 experiments). PBS-treated and Abx-treated groups under each condition were compared for statistical purposes. For all, error bars denote mean T SD; Student's t test, *P < 0.05, **P < 0.01, ***P < 0.001.
through binding to bacterially expressed HBGAs, facilitate productive attachment to, and infection of, B cells. To examine whether intestinal bacteria contribute to NoV infection in vivo, we depleted the intestinal microbiota of wild-type B6 mice before MuNoV infection ( fig. S7) . Indeed, antibiotic depletion of normal intestinal flora resulted in a significant reduction in MuNoV titers (Fig. 4D) , demonstrating a biologically substantial role for enteric bacteria during NoV infection. These reduced titers reflected decreased viral replication because the ratio of replicated to input virus was similar between antibiotictreated and control mice ( fig. S3B ). These collective data are consistent with recent studies of other viruses that have been shown to exploit commensal bacteria for optimal infection, and in particular with the ability of bacterial LPS to stimulate poliovirus attachment to permissive cells (30) (31) (32) .
We have developed a cell culture system for a HuNoV by revealing that the current globally dominant GII.4-Sydney HuNoV strain infects human B cells. This infection is substantially enhanced by free HBGA or by HBGA-expressing bacteria. It is thus likely that previous attempts to culture HuNoVs failed because of the nature of the cell type tested and the absence of stimulatory carbohydrate molecules. Animal studies of the related MuNoVs validate that intestinal B cells are in vivo targets of NoVs and that enteric bacteria are required for efficient infection of susceptible hosts.
